Clinical Trials for Bendamustine

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentECOGHEME2408
05/10/2011
A 3-Arm Randomized Phase II Trial of Bendamustine-Rituximab (BR) Followed by Rituximab vs Bortezomib-BR (BVR) Followed by Rituximab vs BR Follwed by Lenalidomide/Rituximab in High Risk Follicular Lymphoma

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.